99,610 Shares in Azenta, Inc. $AZTA Bought by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management acquired 99,610 Azenta shares worth approximately $3.475 million, representing about 0.23% of the company. Institutional investors collectively own 99.08% of Azenta.
• Analyst sentiment is mixed: Needham maintained a “buy” rating with a $37 target, while the overall consensus is “Hold” with an average price target of $41.20.
• Azenta recently exceeded quarterly expectations, reporting $0.16 in EPS versus $0.11 expected and revenue of $161.18 million versus $149.31 million forecast. The stock opened at $36.76, compared with a 52-week range of $15.93 to $46.41.

Assenagon Asset Management S.A. bought a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 99,610 shares of the company's stock, valued at approximately $3,475,000. Assenagon Asset Management S.A. owned approximately 0.23% of Azenta at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Green Alpha Advisors LLC grew its stake in Azenta by 3.5% in the third quarter. Green Alpha Advisors LLC now owns 9,187 shares of the company's stock valued at $321,000 after purchasing an additional 313 shares in the last quarter. Rockefeller Capital Management L.P. increased its position in Azenta by 98.0% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company's stock worth $46,000 after buying an additional 689 shares during the last quarter. KBC Group NV increased its position in Azenta by 102.2% during the first quarter. KBC Group NV now owns 2,449 shares of the company's stock worth $52,000 after buying an additional 1,238 shares during the last quarter. GAMMA Investing LLC raised its stake in Azenta by 43.8% in the third quarter. GAMMA Investing LLC now owns 4,454 shares of the company's stock valued at $155,000 after buying an additional 1,357 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new stake in Azenta in the second quarter valued at approximately $39,000. Institutional investors own 99.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $37.00 price objective on shares of Azenta in a research report on Monday, September 14th. Wall Street Zen lowered shares of Azenta from a "buy" rating to a "hold" rating in a research report on Sunday. Finally, Weiss Ratings raised shares of Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday, August 26th. Four analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Azenta currently has a consensus rating of "Hold" and an average target price of $41.20.

Azenta Stock Performance

AZTA opened at $36.76 on Thursday. Azenta, Inc. has a fifty-two week low of $15.93 and a fifty-two week high of $46.41. The company has a market capitalization of $1.61 billion, a P/E ratio of -13.32 and a beta of 1.52. The stock has a fifty day moving average of $34.32 and a 200-day moving average of $27.79.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.11 by $0.05. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%. The company had revenue of $161.18 million during the quarter, compared to analysts' expectations of $149.31 million.

Azenta Company Profile

Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.

The company's portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.